PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Clinical trials suggest acai intake may contribute to improved antioxidant defense and attenuation of metabolic stress and inflammation, though considerable heterogeneity was observed [PMID:33555024]
Extracts have shown inhibitory activity in in vivo or ex vivo bioassays using carcinogens [PMID:39312451]; a systematic review of preclinical rodent models described antitumor effects [PMID:29966007]
In rats, an acai pulp-enriched diet induced anxiolytic-like effects and improved memory retention [PMID:36405951]. In mice, acai juice prevented neurobehavioral abnormalities and pro-aging effects induced by methylmercury [PMID:31717801].
Dried acai berry extract reduced the ulcerated area in ethanol-induced gastric ulcer rat models by 48% to 83% depending on dose [PMID:32430960].
Acai pulp and seed extracts promoted jejunal tissue regeneration and protected against 5-fluorouracil-induced mucositis in mice [PMID:32367766, PMID:38428258]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36839349 (2023) — Açaí (Euterpe oleracea Mart.) in Health and Disease: A Critical Review. · Nutrients
- 2.PMID: 38485254 (2024) — Safety Assessment of Palm-Derived Ingredients as Used in Cosmetics. · International journal of toxicology
- 3.PMID: 29966007 (2018) — Anticancer potential, molecular mechanisms and toxicity of Euterpe oleracea extract (açaí): A systematic review. · PloS one
- 4.PMID: 37803612 (2023) — An integrative review of Açaí (Euterpe oleracea and Euterpe precatoria): Traditional uses, phytochemical composition, market trends, and emerging applications. · Food research international (Ottawa, Ont.)
- 5.PMID: 39669170 (2024)